StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Hey Nailoser

<< Previous

Bullboard Posts

Next >>

Comment by IainCaimbeulon Aug 04, 2024 5:37pm

87 Views

Post# 36164010

RE:RE:Hey Nailoser

That is an outright untruth. I am still awaiting a response from rebecca i sent 2 weeks ago. Nice try golum.

I have lots of shares, in the sub 10 cent range. If Stagezero goes broke it will be a minor inconvenience to me but I have the feeling it will be a disaster for you and a few others.

Clutch those pearls a little tighter.

If you are suggesting that Rebecca only shares info with a select few then gee that might be illegal as I hardly think you and the chosen few are company executives. You never cease to amaze, you cannot even make up a convincing fib.

You have absolutely NO idea what is going on

gojotv! wrote:

Those of us who have shares know what's going on, because Rebecca answers our emails.
I guess if you don't know, 4Lies4Ever, you must be a paid manipulator, not a shareholder.